Article
DLK1 downregulation serves as a potential biomarker for disease severity and a therapeutic target in bronchiectasis
2025-07-29
Abstract excerpt
<title>Abstract</title> <p> Background The pathological mechanisms underlying bronchiectasis remain incompletely understood, necessitating novel therapeutic targets. Delta-like homolog 1 (DLK1), a Notch pathway regulator, plays critical roles in tissue repair and inflammation modulation, yet its regulatory role in bronchiectasis pathogenesis remains undefined. Methods This study integrated cis-expression quantit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6176a5dc-1938-527f-b63c-0c2f7ea5df94
- DOI
- 10.21203/rs.3.rs-7090713/v1
